G. Macgrogan et al., PROGNOSTIC VALUE OF P53 IN BREAST INVASIVE DUCTAL CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY ON 942 CASES, Breast cancer research and treatment, 36(1), 1995, pp. 71-81
P53 immunohistochemical detection using DO7 antibody on 942 cases of p
reviously untreated breast invasive ductal carcinoma (IDC) with a medi
an follow up of 117.9 months (89 to 160) was performed. Three hundred
and three (32%) tumors were positive. All positive tumors were taken i
nto account, positivity ranging from 1 to 100% of tumoral cells. The C
hi square test showed significant negative correlation between p53 pos
itivity and age (p = 0.01), estrogen receptor status (p < 0.0001), and
progesterone receptor status (p = 0.0005), and significant positive c
orrelation with tumor grade according to the Scarff, Bloom and Richard
son system (SBR Grade) (p < 0.0001). There was no significant associat
ion with tumor size or nodal status. Concerning the univariate analysi
s, in the whole group and node-positive group (n = 544) p53 positivity
was highly significant for overall survival (OS) (p < 0.0001 and p =
0.0003), disease-free interval (DFI) (p = 0.0001 and p = 0.0005), and
metastasis-free interval (MFI) (p < 0.0001 and p = 0.0003). In the nod
e-negative group (n = 398), p53 was significant with respect to OS (p
= 0.01) and DFI (p = 0.04). P53 positivity came out as an independent
prognostic parameter in the multivariate analysis in the whole group a
nd the node-positive group, though of minor significance compared to a
xillary lymph node status, SBR grade, progesterone receptor status, an
d tumor size.